A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study

L Moreno; LV Marshall; AD Pearson; B Morland; M Elliott; Q Campbell-Hewson; G Makin; SE Halford; G Acton; P Ross; S Kazmi-Stokes; V Lock; A Rodriguez; JF Lyons; AV Boddy; MJ Griffin; M Yule; D. Hargrave

doi:10.1158/1078-0432.CCR-14-1592

A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study

L Moreno, LV Marshall, AD Pearson, B Morland, M Elliott, Q Campbell-Hewson, G Makin, SE Halford, G Acton, P Ross, S Kazmi-Stokes, V Lock, A Rodriguez, JF Lyons, AV Boddy, MJ Griffin, M Yule, D. Hargrave

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	267-273
Number of pages	6
Journal	Clinical Cancer Research
Volume	21
Issue number	2
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-1592
Publication status	Published - 15 Jan 2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-14-1592

Cite this

Moreno, L., Marshall, LV., Pearson, AD., Morland, B., Elliott, M., Campbell-Hewson, Q., Makin, G., Halford, SE., Acton, G., Ross, P., Kazmi-Stokes, S., Lock, V., Rodriguez, A., Lyons, JF., Boddy, AV., Griffin, MJ., Yule, M., & Hargrave, D. (2015). A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study. Clinical Cancer Research, 21(2), 267-273. https://doi.org/10.1158/1078-0432.CCR-14-1592

@article{d72c8d894a254456a3c0c39504dd3ac0,

title = "A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study",

author = "L Moreno and LV Marshall and AD Pearson and B Morland and M Elliott and Q Campbell-Hewson and G Makin and SE Halford and G Acton and P Ross and S Kazmi-Stokes and V Lock and A Rodriguez and JF Lyons and AV Boddy and MJ Griffin and M Yule and D. Hargrave",

year = "2015",

month = jan,

day = "15",

doi = "10.1158/1078-0432.CCR-14-1592",

language = "English",

volume = "21",

pages = "267--273",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "2",

}

Moreno, L, Marshall, LV, Pearson, AD, Morland, B, Elliott, M, Campbell-Hewson, Q, Makin, G, Halford, SE, Acton, G, Ross, P, Kazmi-Stokes, S, Lock, V, Rodriguez, A, Lyons, JF, Boddy, AV, Griffin, MJ, Yule, M & Hargrave, D 2015, 'A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study', Clinical Cancer Research, vol. 21, no. 2, pp. 267-273. https://doi.org/10.1158/1078-0432.CCR-14-1592

TY - JOUR

T1 - A Phase I Trial of AT9283 (a Selective Inhibitor of Aurora Kinases) in Children and Adolescents with Solid Tumors: A Cancer Research UK Study

AU - Moreno, L

AU - Marshall, LV

AU - Pearson, AD

AU - Morland, B

AU - Elliott, M

AU - Campbell-Hewson, Q

AU - Makin, G

AU - Halford, SE

AU - Acton, G

AU - Ross, P

AU - Kazmi-Stokes, S

AU - Lock, V

AU - Rodriguez, A

AU - Lyons, JF

AU - Boddy, AV

AU - Griffin, MJ

AU - Yule, M

AU - Hargrave, D.

PY - 2015/1/15

Y1 - 2015/1/15

U2 - 10.1158/1078-0432.CCR-14-1592

DO - 10.1158/1078-0432.CCR-14-1592

M3 - Article

SN - 1078-0432

VL - 21

SP - 267

EP - 273

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 2

ER -